Trial Profile
An Open Label, Single Dose, Cross-over Study to Assess the Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Arena Pharmaceuticals; Eisai Inc
- 30 Jan 2009 New trial record